Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2025 1.325B
December 31, 2024 1.544B
September 30, 2024 1.411B
June 30, 2024 1.366B
March 31, 2024 1.539B
December 31, 2023 1.656B
September 30, 2023 1.379B
June 30, 2023 1.307B
March 31, 2023 1.214B
December 31, 2022 1.251B
September 30, 2022 950.85M
June 30, 2022 892.14M
March 31, 2022 964.57M
December 31, 2021 1.058B
September 30, 2021 905.19M
June 30, 2021 832.70M
March 31, 2021 852.00M
December 31, 2020 930.41M
September 30, 2020 683.67M
June 30, 2020 605.22M
March 31, 2020 594.74M
December 31, 2019 853.57M
September 30, 2019 673.54M
June 30, 2019 629.70M
March 31, 2019 660.35M
Date Value
December 31, 2018 675.64M
September 30, 2018 568.27M
June 30, 2018 458.87M
March 31, 2018 512.16M
December 31, 2017 519.75M
September 30, 2017 441.93M
June 30, 2017 380.10M
March 31, 2017 372.51M
December 31, 2016 407.21M
September 30, 2016 350.22M
June 30, 2016 328.23M
March 31, 2016 353.75M
December 31, 2015 425.72M
September 30, 2015 350.13M
June 30, 2015 316.85M
March 31, 2015 344.10M
December 31, 2014 447.05M
September 30, 2014 401.96M
June 30, 2014 356.86M
March 31, 2014 379.47M
December 31, 2013 465.03M
September 30, 2013 357.07M
June 30, 2013 332.97M
March 31, 2013 384.25M
December 31, 2012 433.98M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 64.02M
Integrated BioPharma, Inc. 7.671M
Wal-Mart de México SAB de CV 15.30B
Skinvisible, Inc. 10.91M
Kimberly-Clark de México SAB de CV 3.028B